The COVID-19 pandemic has taught us some harsh lessons, and it has also brought some glaring realities back to the surface and one of them is India’s healthcare spend as a percentage of GDP.

India’s healthcare expenditure is still below 2.5 percent, not even half the 5 percent level advocated by the World Health Organisation and a far cry from developed countries like the US, which is at 8 percent.

In this episode of Investment Guide, Chirag Dagli, Fund Manager at DSP Investment Managers, and Prakash Agarwal, Deputy Head-Research at Axis Capital, discuss the opportunity pharma companies present and the spotlight is on hospital and diagnostic companies.

Watch the accompanying video for more.

To watch other videos in this series, click on the CNBC-TV18 Investment Guide tab below.

(Edited by : Priyanka Rathi)

First Published:May 5, 2021 4:18 PM IST